# DoW Toxic Exposures Clinical Trial Award

Source: https://welltoldgrants.com/grants/ht942526terpcta-dow-toxic-exposures-clinical-trial-award/  
Official notice: https://www.grants.gov/search-results-detail/362302

> Defense Health Agency Contracting Activity - DHACA is offering grants to any type of organization. It expects to make one award worth $4.5 million in total. Applications close on November 19, 2026.

| Field | Value |
|---|---|
| Opportunity number | HT942526TERPCTA |
| Agency | Defense Health Agency Contracting Activity - DHACA |
| Status | Open |
| Deadline | November 19, 2026 |
| Award ceiling | not stated |
| Award floor | not stated |
| Expected awards | 1 |
| Total funding | $4.5 million |
| Cost sharing | not required |
| Assistance Listings | 12.420 |

## Who can apply

- Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"

## What the grant funds

Summary: The fiscal year 2026 (FY26) Toxic Exposures Research Program (TERP) Clinical Trial Award (CTA) mechanism supports the advancement, execution, and analysis of clinical trials with the potential to have a significant impact on the prevention, treatment, or management of symptoms, diseases or conditions associated with or resulting from military-related toxic exposures. Proposed projects may range from small proof-of-concept clinical trials (e.g., pilot, first-in-human, phase 0) designed to demonstrate the feasibility or inform the design of more advanced trials, through large-scale trials (including pragmatic clinical trials) to determine efficacy in relevant patient populations. Distinctive Features: To encourage applications that include meaningful and productive collaborations, the FY26 TERP CTA includes a Partnering Principal Investigator Option (PPIO). One Principal Investigator (PI) is identified as the initiating PI, and an additional PI may be identified as a Partnering PI. If recommended for funding, each PI will be named on separate awards. The intent is to support interdisciplinary partnerships, such as those between clinicians and research scientists, that will accelerate the movement of promising interventions/​knowledge products into clinical applications. Partnering should significantly advance the research beyond what would be possible through independent efforts. https://cdmrp.health.mil/pubs/press/2026/terppreann

## Questions people ask

### Who can apply for DoW Toxic Exposures Clinical Trial Award?

Defense Health Agency Contracting Activity - DHACA accepts applications from any type of organization.

### What is the deadline for DoW Toxic Exposures Clinical Trial Award?

Closes November 19, 2026 (19 days left). Confirm the date and time in the official notice on Grants.gov.

### How much funding is available?

About $4.5 million in total for one award.